此組合整合了抗炎、通腑、理氣、止痛功能,精準針對急性胰腺炎(AP)的發病機制。
Acute Pancreatitis (AP) involves complex pathophysiology characterized by severe inflammation, visceral edema, and intestinal dysfunction. The core prescription (ST36, ST39, GB34, PC6) provides non-pharmacological support by activating the Neuro-Endocrine-Immune (NEI) axis.
急性胰腺炎(AP)涉及複雜的病理生理學,表現為嚴重炎症、臟腑水腫及腸道功能障礙。此核心配穴(足三里、下巨虛、陽陵泉、內關)透過激活神經-內分泌-免疫(NEI)軸,提供非藥物治療支持。
-
Zusanli (ST36): The He-point, acts as the primary neuro-modulator. It activates the Vagus Nerve / Cholinergic Anti-inflammatory Pathway.
足三里(ST36): 作為合穴,是主要的經絡神經調控點。它激活迷走神經 / 膽鹼能抗炎通路。
-
Effect: Reduces serum levels of pro-inflammatory factors (TNF-α, IL-6), mitigating the systemic inflammatory response syndrome (SIRS) seen in severe AP.
作用:降低促炎因子(TNF-α、IL-6)的血清水平,減輕重症 AP 中出現的全身炎症反應症候群(SIRS)。
-
Xiajuxu (ST39): The lower He-point of the Small Intestine Meridian, but clinically acts as the specific point for the large intestine in some systems. It promotes smooth bowel movements and reduces intestinal distension, mitigating bacterial translocation.
下巨虛(ST39): 雖為小腸經下合穴,但在某些系統中作為大腸專屬點。它促進腸道通降和減少腹脹,減輕細菌移位。
-
Yanglingquan (GB34): The Influential Point of Tendons/Sinews (筋會), closely located near the common peroneal nerve. Research suggests its stimulation can help regulate the sphincter of Oddi and bile flow, relevant for biliary AP.
陽陵泉(GB34): 筋會,靠近腓總神經。研究表明其刺激有助於調節 Oddi 括約肌和膽汁流動,與膽源性 AP 相關。
-
Neiguan (PC6): The Luo-connecting point of the Pericardium Meridian. It excels at widening the chest (Kuan Zhong), descending rebellious Qi, and providing strong analgesic effects against severe epigastric pain typical of AP.
內關(PC6): 心包經絡穴。擅長寬胸降逆、理氣,對 AP 典型的嚴重上腹部疼痛具有強效鎮痛作用。
This four-point prescription offers a comprehensive therapeutic strategy for AP: ST36 manages systemic inflammation; ST39 ensures gastrointestinal motility; GB34 helps regulate hepatobiliary function; and PC6 controls pain and nausea/vomiting, addressing the pathology across multiple systems.
這組四穴配方為 AP 提供了全面的治療策略:足三里管理全身炎症;下巨虛確保胃腸動力;陽陵泉協調肝膽功能;內關則控制疼痛和噁心/嘔吐,從多系統層面應對病理變化。
Leave a comment